Long-term therapy with sorafenib is associated with pancreatic atrophy. [electronic resource]
Producer: 20160222Description: 314-21 p. digitalISSN:- 1095-8673
- Aged
- Antineoplastic Agents -- administration & dosage
- Atrophy -- chemically induced
- Carcinoma, Hepatocellular -- drug therapy
- China -- epidemiology
- Cohort Studies
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Niacinamide -- administration & dosage
- Pancreas -- pathology
- Pancreatic Diseases -- chemically induced
- Phenylurea Compounds -- administration & dosage
- Sorafenib
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.